Brief: PCI Biotech Gives Update On Preclinical Research Collaboration Agreement With Astrazeneca
13/07/2020 18:35
July 13 (Reuters) - Pci Biotech Holding Asa PCIB.OL :
* REG-PCI BIOTECH: UPDATE ON THE PRECLINICAL RESEARCH
COLLABORATION AGREEMENT WITH ASTRAZENECA
* ANNOUNCED A 6 MONTH EXTENSION OF EVALUATION PERIOD UNDER
ITS
PRECLINICAL RESEARCH COLLABORATION WITH ASTRAZENECA
* EVALUATION OF POTENTIAL FOR A FURTHER COLLABORATION NOW
RUNS TO
END OF 2020
Source text for Eikon: ID:nGNE1mjWVC
Further company coverage: PCIB.OL
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process